This observational study in antiretroviral treatment-experienced, HIV-1-infected adults explored the efficacy of etravirine plus darunavir/ritonavir (DRV group; n = 999) vs. etravirine plus an alternative boosted protease inhibitor (other PI group; n = 116) using pooled European cohort data.
Vingerhoets, J., Calvez, V., Flandre, P., Marcelin, A., CECCHERINI SILBERSTEIN, F., Perno, C.f., et al. (2015). Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: An observational study using pooled European cohort data. HIV MEDICINE, 16(5), 297-306 [10.1111/hiv.12218].
Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: An observational study using pooled European cohort data
CECCHERINI SILBERSTEIN, FRANCESCA;PERNO, CARLO FEDERICO;SANTORO, MARIA;
2015-01-14
Abstract
This observational study in antiretroviral treatment-experienced, HIV-1-infected adults explored the efficacy of etravirine plus darunavir/ritonavir (DRV group; n = 999) vs. etravirine plus an alternative boosted protease inhibitor (other PI group; n = 116) using pooled European cohort data.| File | Dimensione | Formato | |
|---|---|---|---|
|
2015_Efficacy of Etravirine combined with DRV or other ritonavir-boosted protease inhibitors in HIV1 infected patients_Vingerhoets_hivmedicine.pdf
accesso aperto
Licenza:
Copyright dell'editore
Dimensione
272.03 kB
Formato
Adobe PDF
|
272.03 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
